Cosmos Health (COSM) Price to Sales (2014 - 2026)

Cosmos Health (COSM) has reported Price to Sales for 12 consecutive years, with 0.57 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 32.88% year-over-year to 0.57; the trailing twelve-month figure through Jun 2026 stood at 0.15 (down 35.42% YoY), and the FY2025 full-year result was 0.23, down 1.57% from the prior year.
• Price to Sales retreated to 0.57 in Q2 2026 per COSM's latest filing, from 0.73 in the prior quarter.
• Across five years, Price to Sales topped out at 3.04 in Q1 2023 and bottomed at 0.43 in Q3 2022.
• Historically, Price to Sales has averaged 1.3 across 5 years, with a median of 0.89 in 2025.
• The sharpest annual moves came in 2022 and 2023: Price to Sales slumped 92.58% in 2022, then surged 383.2% in 2023.
• Over 5 years, Price to Sales stood at 0.73 in 2022, then jumped by 46.03% to 1.07 in 2023, then dropped by 15.35% to 0.9 in 2024, then declined by 14.78% to 0.77 in 2025, then dropped by 26.09% to 0.57 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 0.57, 0.73, and 0.77 for Q2 2026, Q1 2026, and Q4 2025 respectively.